• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Health Technology Assessment of meningococcal B vaccine (Trumenba) in adolescent in Italy].

作者信息

Boccalini S, Bechini A, Sartor G, Paolini D, Innocenti M, Bonanni P, Panatto D, Lai P L, Zangrillo F, Marchini F, Lecini E, Iovine M, Amicizia D, Landa P

机构信息

Dipartimento di Scienze della Salute, Università degli Studi di Firenze.

Dipartimento di Scienze della Salute, Università degli Studi di Genova.

出版信息

J Prev Med Hyg. 2019 Dec 19;60(3 Suppl 2):E1-E94. doi: 10.15167/2421-4248/jpmh2019.60.3s2. eCollection 2019 Dec.

DOI:10.15167/2421-4248/jpmh2019.60.3s2
PMID:32047867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7007189/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/3660f30c7f5c/jpmh-2019-03-S2-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/27762c0955e8/jpmh-2019-03-S2-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/f81dcd0633ef/jpmh-2019-03-S2-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/db231a817394/jpmh-2019-03-S2-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/b3bea51aa697/jpmh-2019-03-S2-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/fae8fed60630/jpmh-2019-03-S2-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/02a634135e70/jpmh-2019-03-S2-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/98042c9bd00f/jpmh-2019-03-S2-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/8b00fb72d3e6/jpmh-2019-03-S2-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/f6e6ff6e0fd9/jpmh-2019-03-S2-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/e63e1c169d6b/jpmh-2019-03-S2-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/3a53e5e7b15a/jpmh-2019-03-S2-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/2dc3672c9dfa/jpmh-2019-03-S2-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/96876f2ec818/jpmh-2019-03-S2-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/91bfeb5cbfda/jpmh-2019-03-S2-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/9ff444b85eca/jpmh-2019-03-S2-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/3660f30c7f5c/jpmh-2019-03-S2-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/27762c0955e8/jpmh-2019-03-S2-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/f81dcd0633ef/jpmh-2019-03-S2-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/db231a817394/jpmh-2019-03-S2-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/b3bea51aa697/jpmh-2019-03-S2-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/fae8fed60630/jpmh-2019-03-S2-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/02a634135e70/jpmh-2019-03-S2-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/98042c9bd00f/jpmh-2019-03-S2-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/8b00fb72d3e6/jpmh-2019-03-S2-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/f6e6ff6e0fd9/jpmh-2019-03-S2-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/e63e1c169d6b/jpmh-2019-03-S2-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/3a53e5e7b15a/jpmh-2019-03-S2-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/2dc3672c9dfa/jpmh-2019-03-S2-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/96876f2ec818/jpmh-2019-03-S2-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/91bfeb5cbfda/jpmh-2019-03-S2-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/9ff444b85eca/jpmh-2019-03-S2-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53b/7007189/3660f30c7f5c/jpmh-2019-03-S2-g016.jpg

相似文献

1
[Health Technology Assessment of meningococcal B vaccine (Trumenba) in adolescent in Italy].[意大利青少年群体中B型脑膜炎球菌疫苗（Trumenba）的卫生技术评估]
J Prev Med Hyg. 2019 Dec 19;60(3 Suppl 2):E1-E94. doi: 10.15167/2421-4248/jpmh2019.60.3s2. eCollection 2019 Dec.
2
Prospects for eradication of meningococcal disease.消除脑膜炎球菌病的前景。
Arch Dis Child. 2012 Nov;97(11):993-8. doi: 10.1136/archdischild-2012-302036. Epub 2012 Sep 15.
3
Meningococcal serogroup B outbreaks and use of 4CMenB vaccine.B群脑膜炎球菌暴发与4CMenB疫苗的使用
J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):198-201. doi: 10.1331/JAPhA.2014.14512.
4
Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease.针对美国大学校园 B 群脑膜炎球菌疾病爆发的大规模疫苗接种反应成本计算器。
Hum Vaccin Immunother. 2019;15(4):978-986. doi: 10.1080/21645515.2018.1556074. Epub 2019 Jan 16.
5
Authors' response: Meningococcal vaccine antigen diversity in global databases.作者回复：全球数据库中的脑膜炎球菌疫苗抗原多样性。
Euro Surveill. 2016 Apr 14;21(15). doi: 10.2807/1560-7917.ES.2016.21.15.30192.
6
Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction.估计脑膜炎奈瑟菌 C 群通用疫苗接种对意大利的影响及对多组分 B 群疫苗接种的建议。
J Immunol Res. 2015;2015:710656. doi: 10.1155/2015/710656. Epub 2015 Aug 17.
7
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis.为意大利婴儿接种预防B型脑膜炎球菌病的新型多组分疫苗（Bexsero®）：成本效益分析。
Hum Vaccin Immunother. 2016 Aug 2;12(8):2148-2161. doi: 10.1080/21645515.2016.1160177. Epub 2016 May 10.
8
Immunisation against meningococcus B.针对B型脑膜炎球菌的免疫接种。
Lancet. 2013 Sep 7;382(9895):857-8. doi: 10.1016/S0140-6736(13)61861-9.
9
Meningococcal vaccine use in college students.大学生中脑膜炎球菌疫苗的使用情况。
Ann Pharmacother. 2002 Nov;36(11):1776-84. doi: 10.1345/aph.1C024.
10
A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa.北非侵袭性脑膜炎奈瑟菌病的流行病学和疫苗接种策略综述。
Int J Infect Dis. 2021 Mar;104:189-197. doi: 10.1016/j.ijid.2020.11.162. Epub 2020 Nov 20.

引用本文的文献

1
Health Technology Assessment of Vaccines in Italy: History and Review of Applications.意大利疫苗的卫生技术评估：历史与应用综述
Vaccines (Basel). 2024 Sep 24;12(10):1090. doi: 10.3390/vaccines12101090.
2
Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy.远隔效应：从一种罕见现象到癌症治疗的新前沿
Biomark Res. 2024 Sep 4;12(1):98. doi: 10.1186/s40364-024-00628-3.
3
MAGLIO study: epideMiological Analysis on invasive meninGococcaL disease in Italy: fOcus on hospitalization from 2015 to 2019.MAGLIO 研究：意大利侵袭性脑膜炎奈瑟菌病的流行病学分析：重点关注 2015 年至 2019 年的住院情况。

本文引用的文献

1
Lifetime costs of invasive meningococcal disease: A Markov model approach.侵袭性脑膜炎奈瑟菌病的终身成本：马尔可夫模型方法。
Vaccine. 2019 Oct 31;37(46):6885-6893. doi: 10.1016/j.vaccine.2019.09.060. Epub 2019 Oct 5.
2
Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.A、C、W-135 和 Y 群脑膜炎球菌多糖结合疫苗在澳大利亚青少年中的成本效益分析。
Vaccine. 2019 Aug 14;37(35):5009-5015. doi: 10.1016/j.vaccine.2019.07.008. Epub 2019 Jul 10.
3
Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis.
Intern Emerg Med. 2023 Oct;18(7):1961-1969. doi: 10.1007/s11739-023-03377-7. Epub 2023 Aug 1.
4
Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019).成人及其后代中的侵袭性脑膜炎球菌病和B群脑膜炎球菌疫苗接种：意大利的知识、态度和实践（2019年）
Vaccines (Basel). 2023 Feb 22;11(3):508. doi: 10.3390/vaccines11030508.
5
Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention.小儿脑膜炎球菌病：关注流行病学和预防。
Int J Environ Res Public Health. 2022 Mar 29;19(7):4035. doi: 10.3390/ijerph19074035.
6
[ (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy].[意大利引入四价结合疫苗进行抗脑膜炎球菌疫苗接种的（卫生技术评估）]
J Prev Med Hyg. 2021 May 13;62(1 Suppl 1):E1-E128. doi: 10.15167/2421-4248/jpmh2021.62.1s1. eCollection 2021 Mar.
7
Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence.为何意大利应在青少年时期实施B型脑膜炎球菌疫苗接种：现有证据概述
Microorganisms. 2020 Oct 29;8(11):1681. doi: 10.3390/microorganisms8111681.
血清群特异性脑膜炎奈瑟菌携带率的年龄组差异：系统评价和荟萃分析。
BMJ Open. 2019 Apr 20;9(4):e024343. doi: 10.1136/bmjopen-2018-024343.
4
Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases?文化与实时聚合酶链反应在侵袭性脑膜炎奈瑟菌病诊断中的敏感性：培养是否会遗漏更轻微的病例？
PLoS One. 2019 Mar 13;14(3):e0212922. doi: 10.1371/journal.pone.0212922. eCollection 2019.
5
Childhood vaccinations: knowledge, attitudes and practices of paediatricians and factors associated with their confidence in addressing parental concerns, Italy, 2016.儿童疫苗接种：意大利 2016 年儿科医生的知识、态度和实践，以及与他们应对家长关注的信心相关的因素。
Euro Surveill. 2019 Feb;24(6). doi: 10.2807/1560-7917.ES.2019.24.6.1800275.
6
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2019.免疫实践咨询委员会推荐的 18 岁及以下儿童和青少年免疫接种时间表-美国，2019 年。
MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):112-114. doi: 10.15585/mmwr.mm6805a4.
7
The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany.德国 B 群脑膜炎奈瑟菌（MenB）引起的侵袭性脑膜炎球菌病的疾病经济负担。
Vaccine. 2019 Mar 14;37(12):1692-1701. doi: 10.1016/j.vaccine.2019.01.013. Epub 2019 Jan 18.
8
A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use.一种用于青少年和成人的新型B型脑膜炎球菌疫苗：特性及使用方法
J Prev Med Hyg. 2018 Dec 15;59(4):E257-E260. doi: 10.15167/2421-4248/jpmh2018.59.4.1096. eCollection 2018 Dec.
9
Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.意大利可通过疫苗预防的侵袭性细菌性疾病：2007-2016 年全国监测系统与记录住院病例的比较。
Vaccine. 2019 Jan 3;37(1):41-48. doi: 10.1016/j.vaccine.2018.11.047. Epub 2018 Nov 23.
10
[The universal influenza vaccination in children with Vaxigrip Tetra in Italy: an evaluation of Health Technology Assessment].[意大利使用Vaxigrip Tetra对儿童进行通用流感疫苗接种：卫生技术评估]
J Prev Med Hyg. 2018 May 30;59(1 Suppl 1):E1-E86. eCollection 2018 May.